NCT07038369 2026-03-17A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K MutationsAtavistik Bio, IncPhase 1 Active not recruiting134 enrolled
NCT06952660 2026-03-12Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical CancerPfizerPhase 4 Recruiting100 enrolled
NCT07044336 2026-03-05Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)AstraZenecaPhase 3 Recruiting700 enrolled